「esi」の検索結果

Multi-objective optimization framework. NSGA-II, NSGA-III, MOEA/D, Pareto fronts, constraint handling, benchmarks (ZDT, DTLZ), for engineering design and optimization problems.

日本語の概要は準備中です。原文の説明を表示しています。

Identify drug repurposing candidates via target-based, compound-based, and disease-based strategies. Combines drug-target-disease network reasoning with mechanism rationale, clinical-trial precedent, and patent/regulatory feasibility. Use for hypothesis-generating repurposing for orphan diseases, finding existing drugs for new indications, and prioritizing candidates by evidence and feasibility.

日本語の概要は準備中です。原文の説明を表示しています。

Transform GWAS signals into drug targets and repurposing opportunities. Connects GWAS-significant loci to causal genes via fine-mapping/eQTL, then to druggable proteins via DGIdb/OpenTargets, then to existing drugs via ChEMBL. Use for GWAS-to-target hypothesis generation, druggable-fraction analysis of disease loci, and human-genetics-validated drug-repurposing prioritization.

日本語の概要は準備中です。原文の説明を表示しています。

Designs and analyzes stable-isotope-resolved metabolomics (SIRM / isotope tracing / fluxomics) experiments that measure metabolic ACTIVITY via 13C/15N/2H tracers, distinct from steady-state pool profiling. Covers tracer choice, isotopologue vs isotopomer, mass-isotopomer distributions (MID), fractional enrichment, the mandatory natural-abundance + tracer-purity correction (IsoCor, AccuCor), and the metabolic/isotopic steady-state vs non-stationary (INST-MFA) distinction. Use when feeding a labeled tracer and interpreting labeling patterns, correcting raw isotopologue intensities, computing or plotting an MID, or deciding tracing vs abundance profiling. For absolute pool concentration and MRM mechanics see metabolomics/targeted-analysis; for constraint-based genome-scale flux (FBA, not empirical tracing) see systems-biology/flux-balance-analysis; for feature detection see metabolomics/xcms-preprocessing; for pathway enrichment that ignores the pool-vs-flux caveat see metabolomics/pathway-mapping.

日本語の概要は準備中です。原文の説明を表示しています。

Assigns honest lipid annotation levels, designs class-based internal-standard quantification, and runs lipid-aware differential and enrichment analysis with lipidr, guarding against in-source-fragment phantoms, sn-position over-claims, and invalid cross-class quantification. Use when naming or canonicalizing lipid species (shorthand separators, Goslin), deciding shotgun vs RP vs HILIC LC-MS, picking internal standards (SPLASH/EquiSPLASH), interpreting MS-DIAL/LipidSearch output, or comparing lipid classes. For general feature detection see metabolomics/xcms-preprocessing and metabolomics/msdial-preprocessing; for non-lipid annotation confidence see metabolomics/metabolite-annotation; for normalization/QC see metabolomics/normalization-qc; for multivariate stats see metabolomics/statistical-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Multi-method binding pocket detection and druggability assessment. Grid-based, fpocket, and P2Rank detection with druggability scoring, visualization, and cross-structure comparison.

日本語の概要は準備中です。原文の説明を表示しています。

Designs and validates quantitative targeted metabolomics assays (MRM/SRM on triple-quadrupole, PRM on high-resolution instruments) to report absolute concentrations. Covers the internal-standard strategy (external cal -> global IS -> standard addition -> stable-isotope-labeled IS), weighted calibration judged by back-calculated %RE not R-squared, ion-ratio quantifier/qualifier confirmation, matrix-effect/recovery characterization, and ICH M10 method validation. Use when quantifying a closed panel of known metabolites with units, building or validating an LC-MS/MS assay, choosing an IS or calibration weighting, or judging whether a reported concentration is trustworthy. For untargeted feature detection see metabolomics/xcms-preprocessing; for group statistics see metabolomics/statistical-analysis; for flux/MID/tracing see metabolomics/isotope-tracing.

日本語の概要は準備中です。原文の説明を表示しています。

Iterative lead optimization with analyze-reason-generate-verify-evaluate loop. Paper-backed (MT-Mol, DrugR, MultiMol).

日本語の概要は準備中です。原文の説明を表示しています。

Agentic and machine-to-machine payments on Stellar. Covers x402 (HTTP 402 paid APIs via OZ Channels facilitator, fee-sponsored clients) and MPP (Machine Payments Protocol) in both Charge mode (per-request SAC) and Channel mode (off-chain commits, high-frequency). Defaults to USDC (SEP-41 SAC) on `stellar:testnet`/`stellar:pubnet` (CAIP-2). Use when selling a paid API to AI agents, building an x402 client, or designing a payment-channel architecture for high-frequency agent traffic.

日本語の概要は準備中です。原文の説明を表示しています。

System architect and technical design leader. Use when the user asks to talk to Tyler or requests the architect.

日本語の概要は準備中です。原文の説明を表示しています。

React composition patterns that scale. Use when refactoring components with boolean prop proliferation, building flexible component libraries, or designing reusable APIs. Triggers on tasks involving compound components, render props, context providers, or component architecture. Includes React 19 API changes.

日本語の概要は準備中です。原文の説明を表示しています。

Design system and premium UX rules for VenTu (ventu.surf). Use whenever building, restyling, reviewing, or polishing any frontend page, component, map, drawer, or motion. Overrides generic AI aesthetic defaults.

日本語の概要は準備中です。原文の説明を表示しています。

Writes the next failing test based on provided design doc and existing todo tests

日本語の概要は準備中です。原文の説明を表示しています。

Writes work-in-progress code and tests based on design doc

日本語の概要は準備中です。原文の説明を表示しています。

Runs Charted Coding iterations in a loop — route via charted-continue, batch red or green work for an entire test file, commit, then repeat until the PR is complete. Infers design doc and PR number when omitted. Use when the user invokes charted loop, wants batch TDD for a PR test file, or asks to continue charted work with commits.

日本語の概要は準備中です。原文の説明を表示しています。

Reviews a design doc with expert sub-agents

日本語の概要は準備中です。原文の説明を表示しています。

Review trust boundaries, input validation, permissions, abuse resistance, secrets, and safe failure behavior.

日本語の概要は準備中です。原文の説明を表示しています。

Design prototype DataFields, generated component state, custom serializers, and compatibility-safe data contracts.

日本語の概要は準備中です。原文の説明を表示しています。

Design SS14 components as serialized state in the correct assembly.

日本語の概要は準備中です。原文の説明を表示しています。

Design schemas and migrations, tune queries, or plan vector retrieval and database operations. Application API implementation uses oma-backend.

日本語の概要は準備中です。原文の説明を表示しています。

Search academic literature and generate, validate, or compare Knows paper sidecars. Use for claim/evidence analysis and literature synthesis.

日本語の概要は準備中です。原文の説明を表示しています。

Evaluate system boundaries and architectural tradeoffs. Use for architecture decisions, design reviews, and ADRs.

日本語の概要は準備中です。原文の説明を表示しています。

When the user wants to create, optimize, or analyze a referral program, affiliate program, or word-of-mouth strategy. Also use when the user mentions 'referral,' 'affiliate,' 'ambassador,' 'word of mouth,' 'viral loop,' 'refer a friend,' or 'partner program.' This skill covers program design, incentive structure, and growth optimization.

日本語の概要は準備中です。原文の説明を表示しています。

Instructions for translating Google Stitch designs (HTML/Tailwind) into production-ready Flutter/Dart code.

日本語の概要は準備中です。原文の説明を表示しています。